Anti-il6 Treatment of Serious COVID-19 Disease With Threatening Respiratory Failure
Clinical trial NCT04322773 · TERMINATED
Trial details
- NCT number
- NCT04322773
- Sponsor
- Marius Henriksen
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-05
- Primary completion
- 2020-10-08
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.